title: Proteolytic inhibitors: implications on microorganisms development, virulence and pathogenesis.
authors.forename: André Luis Souza
authors.initials: AL
authors.lastname: dos Santos
authors.forename: Cátia Lacerda
authors.initials: CL
authors.lastname: Sodré
authors.forename: Marta Helena
authors.initials: MH
authors.lastname: Branquinha
authors.forename: Claudia Masini
authors.initials: CM
authors.lastname: d'Avila-Levy
mesh_terms: D056893:Alveolata / Q000187:drug effects / Q000472:pathogenicity; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects / Q000472:pathogenicity; D003141:Communicable Diseases / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology; D004352:Drug Resistance, Microbial; D056898:Euglenozoa / Q000187:drug effects / Q000472:pathogenicity; D005658:Fungi / Q000187:drug effects / Q000472:pathogenicity; D006801:Humans; D010447:Peptide Hydrolases / Q000737:chemistry / Q000378:metabolism; D011480:Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D014774:Virulence / Q000187:drug effects
chemical_list: D000890:Anti-Infective Agents; D011480:Protease Inhibitors; D010447:Peptide Hydrolases